Navigation Links
Valor Medical Closes $1.4 Million Convertible Debt and Receives ISO 13485 Certification
Date:11/6/2008

SAN DIEGO, Nov. 6 /PRNewswire/ -- Valor Medical, Inc., a medical device company that has developed a liquid embolic technology for the treatment of cerebral aneurysms, announced today that they have successfully raised $1.4 million in capital through a convertible debt offering. Valor's Chief Executive Officer, Clark Adams stated, "Valor's Board and shareholders had approved raising $1.4 million in capital that will be used to complete clinical trials needed for commercial approval in Europe. Reaching the $1.4 million limit went rather quickly and, unfortunately, could not accommodate all potential investors."

Valor also announced that they have received ISO 13485 certification. This certification is a major step toward commercialization in Europe. Mr. Adams explained that the ISO certification is needed before a medical device company can apply for the European CE Mark that must be received before they are allowed to sell product in Europe. Valor Medical expects to receive CE Mark late 2009 and will begin sales at that time.

"Clinical trial results to date have been positive and the reduction in surgery time is dramatic. The accumulated patient implant time to date has reached over 6.4 years," Mr. Adams announced. Valor Medical expects to sell product by the end of 2009 and will be raising additional capital as the company ramps up sales, marketing and distribution in Europe.

For additional information, visit Valor Medical's web site, http://www.valormedical.com


'/>"/>
SOURCE Valor Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R)
2. PharmAthene to Present Data for Protexia(R) and Valortim(R) at HHS PHEMCE Stakeholders Workshop 2008
3. Cancer Care of Western New York Becomes First Center in Western New York to Treat Cancer with RapidArc(TM) Radiotherapy Technology from Varian Medical Systems
4. Environmental Tectonics Corporation Announces Staff Addition to Its BioMedical Systems Division
5. BioMS Medical to present at Rodman and Renshaw Annual Healthcare Conference
6. China Sky One Medical, Inc. Announces Conference Call to Discuss Third Quarter 2008 Results
7. Global Med Technologies(R), Inc. Partners With Biomedical Synergies to Offer Advanced Tissue Tracking Solutions for Hospitals and Surgery Centers
8. Cepheid Accelerates Direct Sales Channel in UK With Pending Acquisition of Medical Distributor Stretton Scientific
9. VNUS Medical Technologies, Inc. Announces the Hiring of Guido Smeets, MD, as Vice President of Clinical Research and Chief Medical Officer
10. Occlutech Obtains Favourable Court Ruling in Patent Litigation in The Hague Against AGA Medical
11. VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... NEW YORK , 27. März 2015 ... Vilcek Prize in Biomedical Science für seine ... wie Proteine zwischen Zellkompartimenten transportiert werden, sowie ... den Zellen zur Reaktion auf Stress nutzen, ... zusammenhängt. Dr. Walter ist Professor für Biochemie ...
(Date:3/27/2015)... March 27, 2015  Peter Walter was chosen as ... his pioneering work on how proteins are transported between ... regulatory mechanism that cells use to handle stress tied ... a professor of biochemistry at the University of California, ... a range of human diseases related to defective protein ...
(Date:3/27/2015)... , March 27, 2015  CASI Pharmaceuticals, Inc. (Nasdaq: ... acquisition, development and commercialization of innovative therapeutics addressing cancer ... with a commercial focus on China ... 12 months ended December 31, 2014.  ... or ($0.05) per share, for the three months ended ...
(Date:3/26/2015)... Bruno, CA (PRWEB) March 26, 2015 ... (CRO), announced today several management and executive appointments ... of Chief Financial Officer (CFO) and member of the ... President of Business Operations, and Sue Dowden will assume ... Taricco, co-founder and current Chief Operations Officer (COO), has ...
Breaking Biology Technology:Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 2Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 3Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 4German-born cell biologist Peter Walter wins the 2015 Vilcek Prize in Biomedical Science 2German-born cell biologist Peter Walter wins the 2015 Vilcek Prize in Biomedical Science 3CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 2CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 3CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 4CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 5CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 6PRC Clinical Announces Key Management Appointments and Launches East Coast Operations 2PRC Clinical Announces Key Management Appointments and Launches East Coast Operations 3
... VANCOUVER, Oct. 31 /PRNewswire-FirstCall/ - Beanstalk Capital Ltd. ... to the Company,s press,release dated October 16, 2007, ... announced that they had entered into an arm,s ... Agreement"),the Company and iCo would now like to ...
... Corporation plc,(NASDAQ: AMRN ) ("Amarin" or the "Company") ... will present at the Acumen,BioFin Rodman & Renshaw 9th ... Eastern time. The conference will be held on November,5 ... The presentation will be simultaneously webcast and a ...
... Provides Revised Timing on Interim Celgosivir Viral Kinetics Study ... ... Oct. 31 /PRNewswire-FirstCall/ - MIGENIX Inc.,(TSX: MGI; OTC: MGIFF), a clinical-stage developer ... Renshaw 9th Annual,Healthcare Conference being held at the New York Palace Hotel ...
Cached Biology Technology:Beanstalk Capital Ltd. and iCo Therapeutics Inc. amend arrangement agreement 2Amarin Corporation to Present at Acumen BioFin Rodman & Renshaw Ninth Annual Healthcare Conference 2Amarin Corporation to Present at Acumen BioFin Rodman & Renshaw Ninth Annual Healthcare Conference 3MIGENIX to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 2MIGENIX to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 3
(Date:3/24/2015)... Fla. , March 24, 2015   ... management solutions, today announced that its U.are.U ® ... accessory retailer Goorin Bros . to achieve ... biometrics-based solution secures access to the POS terminal, ... increased risk of data breaches. ...
(Date:3/23/2015)... 23, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... growing mobile commerce market, announces its biometric payment technology, the ... CNBC television starting March 30 th . ... New York markets. ... excited about our new ad campaign following the recent initial ...
(Date:3/20/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/vkzvcs/iris_biometrics ) ... Global Strategic Business Report" report to their offering. ... in US$ Thousands. The report provides separate comprehensive analytics for ... , Europe , Asia-Pacific ... Latin America . Annual estimates and ...
Breaking Biology News(10 mins):Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5
... Calif. Conservation biologist Michael Allen will give a ... 6 titled "In the Crosshairs: California,s Environment." The hour-long lecture ... Doors open at 6:15 p.m. Seating is open. In his ... Conservation Biology at UC Riverside, plans to discuss what the ...
... STILLWATER, Okla. , April 27 Southwest Bancorp, Inc. (Nasdaq: ... offering of 4,000,000 shares of common stock at a price to the public ... million .  The offering was increased from the previously announced offering size of ... April 29, 2010 . , , ...
... Recently the media has begun to criticize those ... financial reform legislation, or Consumer Financial Protection Agency (CFPA).  Although ... weeks, possibly due to the fact that our Senate is ... of the sweeping bill, we are still not seeing this ...
Cached Biology News:Public lecture at UC Riverside to highlight California's environment 2Southwest Bancorp, Inc. Announces Pricing of $50 Million Underwritten Public Offering of Common Shares 2Southwest Bancorp, Inc. Announces Pricing of $50 Million Underwritten Public Offering of Common Shares 3Pay1Day Asks, Who is Writing our Proposed Consumer Protection Bill? 2
... protein size markers are a mixture of ... to 100 kDa. The markers provide precise ... after staining with Coomassie blue. Because each ... sequence, the markers can also be detected ...
Mouse monoclonal antibody to ACP2 - acid phosphatase 2, lysosomal...
... 220 V, is used for agitation and mixing ... staining and destaining of gels and blots, and ... (8-40 rpm) and can handle a maximum load ... two 29 x 21 cm platforms covered with ...
... (3-ethylbenzthiazoline-6-sulfonic Acid) Clear to very pale ... H 2 O 2 in a citrate ... that is soluble, safe, convenient and has good ... intense blue-green color that can be measured at ...
Biology Products: